Search

Investigator initiated independent study included higher risk patients such as those with metastatic disease, large tumors, and comorbidities, as compared to IceCure's ICE3 study which treated early-stage breast cancer patients [...]

Study published in the peer reviewed journal Breast Cancer Excellent cosmetic outcomes, high degree of patient satisfaction, and improved quality of life post-cryoablation Strategic distribution partner of ProSense in Japan, [...]

- Lunit SCOPE HER2 and Lunit SCOPE ER/PR significantly improve pathologist concordance and accuracy, paving the way for improved breast cancer molecular subtype analysis for informed decision-making and precision patient [...]

University of Michigan Releases Health Impact Report on Dynami Foundation Partnership DETROIT, Nov. 1, 2023 /PRNewswire/ -- The Dynami Foundation has funded groundbreaking new research and support for lobular breast [...]

Disappearance of lesions and absence of residual malignant cells in Luminal-A group considered to be predictive for the complete effectiveness of the treatment This is the latest in a growing [...]

Research Will Lead to Potential New Way to Promote Health Literacy to Consumers BALTIMORE, April 17, 2023 /PRNewswire/ -- As more consumers turn to the newly available ChatGPT for health [...]

NEW YORK, March 16, 2023 /PRNewswire/ -- 2023 Europe Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor-- A 38-Country Database and Analysis, [...]

The study, conducted at Institut Curie and Maccabi Healthcare Services, demonstrated very high accuracy for Ibex AI in detecting breast cancer across wide variety of subtypes, including rare special types [...]

Analysis of more than 1.1 million test results across the United States suggests more people are living with undiagnosed cancer than before the pandemic, with potential for worse outcomes and [...]

NEW YORK, June 20, 2022 /PRNewswire/ -- As per Zion Market Research study,The global https://www.zionmarketresearch.com/report/breast-cancer-liquid-biopsy-market achieved revenue growth of USD 87.64 million in 2021 and it is expected to grow [...]

- Acceptance of immunohistochemistry (ICH) and fluorescence in situ hybridization (FISH) as gold standard for HER2 breast cancer testing drives adoption -Clinical advantages of chromogenic in situ hybridization (CISH) for [...]

DUBLIN, Feb. 24, 2022 /PRNewswire/ -- The 'Europe Breast Cancer Screening Market, Forecast 2022-2027, Industry Trends, Share, Insight, Growth, Impact of COVID-19, Company Analysis' report has been added toResearchAndMarkets.com's offering. [...]

NIJMEGEN, Netherlands, Feb. 14, 2022 /PRNewswire/ -- ScreenPoint Medical's Transpara AI decision support system can help radiologists to identify potential breast cancers earlier and faster, according to a new study [...]

The Breast Cancer Screening Market Size is driven by increasing number of breast cancer cases, growing geriatric population and rising adoption of technology for screening purpose. The imaging test segment [...]

DUBLIN, Oct. 13, 2021 /PRNewswire/ -- The 'HER2+ Breast Cancer - Global Drug Forecast and Market Analysis to 2030' report has been added toResearchAndMarkets.com's offering. The Global HER2+ market is [...]

DUBLIN, Sept. 13, 2021 /PRNewswire/ -- The 'Breast Cancer Diagnostics Global Market Report 2021: COVID-19 Growth and Change to 2030' report has been added toResearchAndMarkets.com's offering. The global breast cancer [...]

Market Availability & Increasing Number Of Clinical Trials To Drive United States Breast Cancer Drug Market Says Kuick Research NEW DELHI, April 12, 2021 /PRNewswire/ -- 'US Breast Cancer Drug [...]

SAN DIEGO, Nov. 20, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information [...]

DUBLIN, Sept. 23, 2020 /PRNewswire/ -- The 'Global Next-Generation Breast Cancer Diagnostic and Screening Market: Focus on Products, Technologies, Cancer Sub-Type, End Users, Country Data (14 Countries), and Competitive Landscape [...]

Global Next-Generation Breast Cancer Diagnostics and Screening Market to Reach $10.48 Billion by 2030 NEW YORK, Aug. 11, 2020 /PRNewswire/ -- Read the full report: https://www.reportlinker.com/p05949918/?utm_source=PRNMarket Report Coverage - Next [...]

NEW YORK, June 24, 2020 /PRNewswire/ -- The Asia Pacific breast cancer screening was valued at US$ 798.57 million in 2019 and is projected to reach US$ 1,120.77 million by [...]

NEW YORK, May 7, 2020 /PRNewswire/ -- The breast cancer screening was valued at US$ 4,638.63 million in 2019 and is projected to reach US$ 6,209.25 million by 2027; it [...]

Recommendations align with protocols outlined in ImpediMed's Lymphedema Prevention Program CARLSBAD, Calif., and BRISBANE, Australia, Feb. 13, 2020 /PRNewswire/ -- ImpediMed Limited (ASX.IPD), a medical software technology company that non-invasively [...]

NEW YORK, Feb. 10, 2020 /PRNewswire/ -- 'US Breast Cancer Drug Market, Price, Dosage & Clinical Pipeline Insight 2025' Report Highlights: Read the full report: https://www.reportlinker.com/p05770998/?utm_source=PRN -- US Breast Cancer [...]

DUBLIN, Jan. 6, 2020 /PRNewswire/ -- The 'Imaging Innovations for Breast Cancer Diagnosis' report has been added to ResearchAndMarkets.com's offering. This research service (RS) showcases the technology innovations in the [...]

DUBLIN, June 27, 2019 /PRNewswire/ -- The 'Breast Cancer Diagnostic and Treatment Devices' report has been added toResearchAndMarkets.com's offering. This analysis includes a discussion of competitors, markets (current and future), [...]

Participating in the Blue Cross Blue Shield Alliance for Health Research, Yale researchers accessed Blue Cross Blue Shield Axis, the largest source of commercial insurance claims CHICAGO, March 22, 2019 [...]

Clinical Study Shows That VR Intervention Improves Sleep, Quality of Life BOSTON, Feb. 21, 2019 /PRNewswire/ -- VRHealth, the healthcare technology company providing specialized virtual reality (VR) technology solutions and [...]

DUBLIN, Jan. 29, 2019 /PRNewswire/ -- The 'Global Breast Cancer Partnering 2012 to 2018' report has been added toResearchAndMarkets.com's offering. The Global Breast Cancer Partnering Terms and Agreements since 2012 [...]

ROCKVILLE, Maryland, December 10, 2018 /PRNewswire/ -- Cancer profiling market revenues surpassed US$ 900 million in 2018, according to Fact.MR's latest study. Growing at a subdued 4% y-o-y, the study [...]

NEW YORK, August 22, 2018 /PRNewswire/ --Frontier Pharma: Breast Cancer - First-in-Class Innovation Underlies Immunotherapeutic Potential and Pipeline Diversification for Late-Stage Breast Cancer Read the full report: https://www.reportlinker.com/p05485953 Summary Breast [...]

The national campaign aims to educate black women about their breast cancer risk to address disparities NEW YORK, May 22, 2018 /PRNewswire/ -- Black women in the U.S. are 40 [...]

Germany is the biggest Breast Cancer Therapeutics Market followed by other European countries; Poland breast cancer therapeutics market is estimated to grow with highest CAGR of above 10% in the [...]

Test only reports 3 out of more than 1,000 known BRCA mutations and negative result doesn't rule out increased cancer risk SILVER SPRING, Md., March 6, 2018 /PRNewswire-USNewswire/ -- The [...]

DUBLIN, March 6, 2018 /PRNewswire/ -- The 'Global Breast Cancer Partnering 2012 to 2018' report has been added toResearchAndMarkets.com's offering. The Global Breast Cancer Partnering Terms and Agreements since 2012 [...]

LONDON, Nov. 16, 2017 /PRNewswire/ --The Global Breast Cancer Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world's [...]

With over a 99 percent negative predictive value, a liquid biopsy test can help clinicians manage difficult-to-diagnose dense breast patients NEW YORK, Oct. 25, 2017 /PRNewswire/ -- A new study [...]

LONDON, Oct. 5, 2017 /PRNewswire/ --Breast Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017 Summary Download the full report: https://www.reportbuyer.com/product/4415889GlobalData's Medical Devices sector report, 'Breast Cancer Diagnostic Tests - [...]

As reported in JNCCN, a recent study by researchers at The University of Sydney found that 29% of breast cancer clinical trials lack control arms consistent with the standard of [...]

NEW YORK, Sept. 14, 2017 /PRNewswire/ -- The Global Breast Cancer Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by [...]

LONDON, Aug. 31, 2017 /PRNewswire/ -- China molecular diagnostics market is expected to be more than USD 1.5 Billion by the year 2022. As a part of the evolution of [...]

NEW YORK, Aug. 1, 2017 /PRNewswire/ --Provides comprehensive understanding and unprecedented access to breast cancer partnering deals and agreements entered into by the worlds leading healthcare companies. Description The Global [...]

Get 10% Free Customization in this Report LONDON, July 17, 2017 /PRNewswire/ -- Asia breast cancer screening market size is expected to cross over US$ 4 Billion by 2022. China, [...]

LONDON, July 17, 2017 /PRNewswire/ --Get 10% Free Customization in this Report Breast Cancer Screening Market is expected to be more than US$ 20 Billion by 2022. Breast cancer is [...]

DUBLIN, July 11, 2017 /PRNewswire/ -- Research and Markets has announced the addition of the 'Worldwide Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast' report to their offering. [...]

'Global Breast Cancer Predictive Genetic Testing Market Outlook 2022' report analyzes the various aspects related to the emergence and development of breast cancer genetic test market across the globe. LONDON, [...]

Study of Videssa Breast shows 'liquid biopsy' after abnormal mammogram and other imaging can help rule out breast cancer, reduce breast biopsy by up to 67 percent in women under [...]

Collaborators at Mayo Clinic Secure New $3.7 Million Grant from U.S. Department of Defense Second TapImmune T-cell vaccine candidate to be tested in a DoD-funded study JACKSONVILLE, Fla., March 14, [...]

MarketReportsOnline.com adds Global Breast Cancer Market: Industry Analysis & Outlook (2017-2021) research report of 70 pages on the breast cancer industry to the healthcare intelligence collection of its research store. [...]

DUBLIN, Jan 20, 2017 /PRNewswire/ -- Research and Markets has announced the addition of the http://www.researchandmarkets.com/research/spnb7m/europe_breast report to their offering. The report provides insights into Breast Cancer epidemiology, Breast Cancer [...]